|
Xu, S X; Monsma Jr, F J; Sibley, D R et al. (1992) Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci 50:383-96
|
|
Kirch, D G; Taylor, T R; Creese, I et al. (1992) Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors. J Pharm Pharmacol 44:89-92
|
|
Creese, I; Sibley, D R; Xu, S X (1992) Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies. Neurochem Int 20 Suppl:45S-48S
|
|
Tepper, J M; Creese, I; Schwartz, D H (1991) Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis. Brain Res 559:283-92
|
|
Xu, S X; Hatada, Y; Black, L E et al. (1991) N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain. J Pharmacol Exp Ther 257:608-15
|
|
van Tol, H H; Riva, M; Civelli, O et al. (1990) Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level. Neurosci Lett 111:303-8
|
|
Riva, M A; Creese, I (1989) Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. Mol Pharmacol 36:211-8
|
|
Riva, M A; Creese, I (1989) Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol. Mol Pharmacol 36:201-10
|
